Ustekinumab Clinical Trials

4 actively recruiting trials across 3 locations

▲ +1 trial since June 2026

Also known as: STELARA, Stelara

Pipeline

Phase 2: 2

Top Sponsors

University of California, San Diego1
Swiss Dermatology Network for Targeted Therapies1
NYU Langone Health1
M.D. Anderson Cancer Center1

Indications

Arthritis3
Psoriasis2
Rheumatic Disease1
Psoriatic Arthritis1
Crohn Disease1

Other1 trial

Swiss Dermatology Network of Targeted Therapies (SDNTT)

La Jolla, California1 trial

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego

New York, New York1 trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NYU Langone Health

Phase 2

Houston, Texas1 trial

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

The University of Texas M. D. Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.